RFA-OH-23-001: Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
Closed
This grant is closed. A newer notice from the same program is open now: Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) (RFA-OH-26-015). Status: Closes December 8, 2026 (31 days left). It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2022.
Centers for Disease Control and Prevention - ERA offered grants of up to $500,000 (at least $300,000) to any type of organization. It expected to make about 8 awards worth $4.0 million in total. Applications closed on December 6, 2022.
From the official notice on Grants.gov, last changed August 29, 2022. Checked November 7, 2026.
- Award ceiling$500,000
- Award floor$300,000
- Total funding$4.0 million
- Expected awards8
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| RFA-OH-26-015 | May 8, 2026 | Closes December 8, 2026 (31 days left) | Open |
Key dates
| Posted | August 29, 2022 |
|---|---|
| Deadline | December 6, 2022 |
| Archived by Grants.gov | January 5, 2023 |
Who can apply
This opportunity was open to any type of organization.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
N/A
Is this a realistic fit?
- Past Occupational Safety and Health Program awards averaged $1.9 million; this notice allows up to $500,000 per award.
- No cost sharing or match is required.
What the grant funds
NIOSH supports exploratory and developmental research projects (R21) that test innovative interventions to reduce risk factors associated with the leading causes of morbidity and mortality with respect to individuals, including enrolled World Trade Center (WTC) responders and certified-eligible WTC survivors, receiving monitoring and/or treatment under subtitle B, of the James Zadroga 9/11 Health and Compensation Act of 2010 (Public Law 111–347, as amended by Public Laws 114–113 and 116–59). NIOSH seeks to achieve a suitable mix of projects and interventions focusing on sustainable health behaviours and lifestyle factors such as nutrition and diet, sleep hygiene, stress management and positive psychology, physical activity, social connectedness, and avoidance of substance misuse that influence quality of life, disease progression and recurrence, survival, adverse events, and other health-related outcomes among WTC Health Program members. This announcement invites applications from both experienced and early-career researchers. Importantly, applicants are expected to propose research approaches for which there is likely to be minimal or no preliminary data.
Who has won Occupational Safety and Health Program grants before
From fiscal 2021 to 2025, Occupational Safety and Health Program (93.262) awarded $590 million across 305 grant awards, an average of $1.9 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| City of New York | New York | 1 | $39.5 million |
| CPWR: the Center for Construction Research and Training | Maryland | 2 | $27.2 million |
| The University of Iowa | Iowa | 5 | $23.6 million |
| University of Illinois | Illinois | 5 | $21.2 million |
| Icahn School of Medicine at Mount Sinai | New York | 16 | $18.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, RFA-OH-26-015, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-OH-23-001 still open?
No. It closed on December 6, 2022. A newer notice is open: RFA-OH-26-015, closes December 8, 2026 (31 days left).
Who can apply for Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)?
Centers for Disease Control and Prevention - ERA accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)?
Closed December 6, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $500,000 each. About $4.0 million in total across about 8 awards.
Who has won Occupational Safety and Health Program grants before?
The largest recipients over five fiscal years were City of New York, CPWR: the Center for Construction Research and Training, The University of Iowa. The program made 305 awards worth $590 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)